Mostovoĭ A V, Aleksandrovich Iu S, Sapun O I, Trifonova E G, Tret'iakova E P, Bogdanova R Z, Karpova A L
Anesteziol Reanimatol. 2009 Jan-Feb(1):43-6.
Respiratory distress syndrome (RDS) is one of the principal causes of death in very and extremely low birth weight neonatal infants. Surfactant replacement therapy is the treatment of choice today. The paper analyzes the impact of different periods of Curosurf administration on the outcome of disease and shows it necessary to administer surfactants in this group of patient as soon as possible.
呼吸窘迫综合征（RDS）是极低出生体重和超低出生体重新生儿死亡的主要原因之一。表面活性剂替代疗法是目前的首选治疗方法。本文分析了不同时期给予珂立苏对疾病转归的影响，并表明在这类患者中尽早给予表面活性剂是必要的。
